Axsome Therapeutics Competitors and Similar CompaniesClear all

Axsome Therapeutics's competitors and similar companies include InSite Clinical Research, Anavex and Seres Therapeutics.

	Axsome Therapeutics Axsome Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for the management of central nervous system disorders.	InSite Clinical Research InSite Clinical Research is a company that performs phase I-IV clinical research trials.	Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.	Seres Therapeutics Seres Therapeutics is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products.
Founding Date	Founding Date 2012	Founding Date 2004	Founding Date 2006	Founding Date 2010
Type	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development healthtech life sciences pharma therapy	Tags Healthcare clinical research drug development	Tags Healthcare biotech clinical research drug development healthtech life sciences oncology pharma therapy	Tags Healthcare biotech drug development healthtech life sciences pharma therapy
Locations	Locations New York, US HQ New York, US	Locations DeSoto, US HQ De Soto, US	Locations New York, US HQ Reno, US	Locations Cambridge, US HQ
Employees	Employees 4111% increase	Employees 24	Employees 1623% increase	Employees 23346% decrease
Valuation ($)	Valuation ($) 4.3 b	Valuation ($) N/A	Valuation ($) 484.6 m	Valuation ($) 131.2 m
Financial
Revenue (est.)	Revenue (est.) $638.5m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $789k (FY, 2025)
Net income	Net income ($183.2m) (FY, 2025)	Net income N/A	Net income ($46.4m) (FY, 2025)	Net income $5.7m (FY, 2025)
Funding
Total funding raised	Total funding raised $ 7m	Total funding raised N/A	Total funding raised $ 12.6m	Total funding raised $ 113m